The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia

被引：32

作者：

Gianni, Francesca ^{[1
]}

Belver, Laura ^{[1
]}

Ferrando, Adolfo ^{[1
,2
,3
]}

机构：

[1] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA

[2] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA

[3] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA

来源：

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE | 2020年 / 10卷 / 03期

关键词：

HEMATOPOIETIC STEM-CELLS; OF-FUNCTION MUTATIONS; ONCOGENIC TRANSCRIPTIONAL PROGRAM; SECRETASE INHIBITOR PF-03084014; DELTA-LIKE; TUMOR-SUPPRESSOR; C-MYC; CHROMOSOMAL TRANSLOCATION; HOMEOBOX GENE; TAL1; COMPLEX;

D O I：

10.1101/cshperspect.a035246

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy derived from early T-cell progenitors. The recognition of clinical, genetic, transcriptional, and biological heterogeneity in this disease has already translated into new prognostic biomarkers, improved leukemia animal models, and emerging targeted therapies. This work reviews our current understanding of the molecular mechanisms of T-ALL.

引用

页数：28

共 50 条

[31] How I treat T-cell acute lymphoblastic leukemia in adults
Litzow, Mark R.
Ferrando, Adolfo A.
BLOOD, 2015, 126 (07) : 833 - 841
[32] MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia
Gebarowska, Katarzyna
Mroczek, Anna
Kowalczyk, Jerzy R.
Lejman, Monika
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
[33] Inactivation of LEF1 in T-cell acute lymphoblastic leukemia
Gutierrez, Alejandro
Sanda, Takaomi
Ma, Wenxue
Zhang, Jianhua
Grebliunaite, Ruta
Dahlberg, Suzanne
Neuberg, Donna
Protopopov, Alexei
Winter, Stuart S.
Larson, Richard S.
Borowitz, Michael J.
Silverman, Lewis B.
Chin, Lynda
Hunger, Stephen P.
Jamieson, Catriona
Sallan, Stephen E.
Look, A. Thomas
BLOOD, 2010, 115 (14) : 2845 - 2851
[34] MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia
Del Gaizo, Martina
Sergio, Ilaria
Lazzari, Sara
Cialfi, Samantha
Pelullo, Maria
Screpanti, Isabella
Felli, Maria Pia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
[35] RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications
Gianfelici, Valentina
Chiaretti, Sabina
Demeyer, Sofie
Di Giacomo, Filomena
Messina, Monica
La Starza, Roberta
Peragine, Nadia
Paoloni, Francesca
Geerdens, Ellen
Pierini, Valentina
Elia, Loredana
Mancini, Marco
De Propris, Maria Stefania
Apicella, Valerio
Gaidano, Gianluca
Testi, Anna Maria
Vitale, Antonella
Vignetti, Marco
Mecucci, Cristina
Guarini, Anna
Cools, Jan
Foa, Robin
HAEMATOLOGICA, 2016, 101 (08) : 941 - 950
[36] Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia
Ong, Jolynn Zu Lin
Tan, Tze King
Wang, Lu
Tan, Shi Hao
Sanda, Takaomi
HAEMATOLOGICA, 2024, 109 (05) : 1359 - 1372
[37] TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia
Sanda, Takaomi
Leong, Wei Zhong
EXPERIMENTAL HEMATOLOGY, 2017, 53 : 7 - 15
[38] The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response
Martelli, Alberto M.
Paganelli, Francesca
Fazio, Antonietta
Bazzichetto, Chiara
Conciatori, Fabiana
McCubrey, James A.
CANCERS, 2019, 11 (05)
[39] Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia
Tan, Tze King
Zhang, Chujing
Sanda, Takaomi
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 5 - 17
[40] T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development
Thomas, Xavier
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (01) : 37 - 52

← 1 2 3 4 5 →